Exposure of human breast cancer cells to the anti-inflammatory agent indomethacin alters choline phospholipid metabolites and Nm23 expression

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Exposure of human breast cancer cells to the anti-inflammatory agent indomethacin alters choline phospholipid metabolites and Nm23 expression'. Together they form a unique fingerprint.

Medicine & Life Sciences